Skip to content
PeptideRank
Kin Meds logo

Provider review

Kin Meds cost: $249/mo tirzepatide

Its FAQ names one "exclusive" pharmacy; its Returns Policy ships from a different one.

Kin Meds' FAQ says it "works exclusively with Rush Pharmacy" (rushpharmacy.com, Oviedo, FL) — but its own Returns and Refund Policy separately lists the return address for the same prescription products as "Kin Meds/Strive Pharmacy" (Gilbert, AZ), a real, live, unedited contradiction about who actually fills the order.

Verified August 2026

Reviewed by Marcus Webb

Transparency scorecard

2 of 4 disclosed openly

What Kin Meds discloses about itself, read from its own pages — not estimated.

Pharmacy named & regulated

Not disclosed

Does not name a pharmacy or state a regulatory category anywhere on its own site.

State coverage published

Not disclosed

Publishes no state coverage list — availability is something you learn during signup.

A real price is published

Disclosed

A real dollar figure is published on its own site, not estimated.

No hidden commitment trap

Disclosed

The advertised price is the ongoing price — no prepay or auto-refill required to unlock it.

This review's stake, stated plainlysome of the outbound links on this site are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.

At a glance

Visit Kin Meds

Pharmacy

Not categorized

Labs

Not stated

States

Not published

On this page

What it actually costs

What this price covers

Medication

Included

Provider visits

Included

Shipping

Not confirmed

Lab work

Not disclosed

Coaching

Not disclosed

See plans at Kin Meds

Prices read from Kin Meds's own site · August 2026

What they advertise

Kin Meds' own GLP-1/GIP page headlines "Starts At $249" for its Personalized GLP-1/GIP (tirzepatide) product, a "30-day supply of the medication," with a flat "Same Price. Every Dose" claim printed beside it — no dose tiers found anywhere on the page. Its own GLP-1 page separately headlines "Personalized GLP-1" (a formulation its own copy confirms "contains semaglutide," combined with B12) at "$199" — and, on that same page, states a direct 503(A) compounding-pharmacy category, a claim neither the FAQ nor the Returns and Refund Policy repeats.

What you actually pay

$249/month (GLP-1/GIP) and $199/month (semaglutide-containing GLP-1) are recorded here as the standing recurring charges, consistent with the pages' own "30-day supply... shipped every 30 days" cadence language and the absence of any separate membership fee or intro-price footnote anywhere on the site. It could not independently confirm either figure against Kin Meds' own live checkout: the "Take Quiz" funnel (quiz.kinmeds.com) is a separate booking app that shows no price when it first loads, and it could not be unavailable this session to walk it interactively — the same verification-limitation shape as Viv Health's review. Sermorelin is $349 a month.

Money you will meet later

  • No membership, subscription, or account fee separate from the medication price appears anywhere on its site.
  • Once an order is placed, Kin Meds' own FAQ states it "cannot be changed or cancelled" — a real constraint on the standing recurring charge, even without a separate fee attached to it.

The bottom line

Kin Meds (Manhattan Beach, CA) is a live, operating telehealth company selling compounded tirzepatide, compounded semaglutide, branded GLP-1 referrals (Wegovy, Zepbound, Foundayo), a sermorelin injection, NAD+, glutathione, and TRT. Nothing here rises to what got MEDVi excluded from this site outright — documented deepfaked patient photos and fabricated physician personas. No independent journalism names Kin Meds beyond syndicated coverage of its own FDA letter. It also names no individual physician anywhere, only an "independent licensed physician network" — so unlike Viv Health, whose two named doctors both resolve in the CMS NPI Registry, Kin Meds offers no clinician to look up at all. The FDA letter's own addressee address matches the address Kin Meds publishes site-wide, a real operating company at the address FDA mailed it to. That clears the bar this site draws between a disclosable knock and a disqualifying one. What remains: a real, dated FDA warning letter (MARCS-CMS 721450, February 20, 2026) over a mislabeled-compounder claim plus two separately-cited marketing claims implying FDA approval, and — found independently of that letter — a real, live contradiction on Kin Meds' own site about which pharmacy actually fills a prescription.

Kin Meds appears on our sermorelin provider ranking, our tirzepatide provider ranking, our semaglutide provider ranking and our combined weight loss injections ranking. Nothing on this page is a performance claim.

Who it is for, and who it is not

A good fit if

  • You've read Kin Meds' FDA warning letter and are satisfied it's a disclosable mislabeled-compounder-plus-marketing-claims citation — the same shape as Strut Health's, BluefitMD's, Ivim Health's, and Viv Health's letters already here — rather than a documented fraud pattern.
  • You want a checkable trust badge that actually resolves — Kin Meds' own LegitScript seal (ID 29592772) resolves at LegitScript's own registry.
  • A single flat price with no dose-tier structure to decode is what you want — Kin Meds' own "Same Price. Every Dose" claim held up on both the tirzepatide and sermorelin anywhere on its site, unlike several peers here.

Look elsewhere if

  • A straight answer about which pharmacy fills your prescription matters — Kin Meds' own FAQ says it works "exclusively" with one pharmacy, and its own Returns Policy sends the same prescriptions to a different one.
  • You might need to change or cancel an order after placing it — Kin Meds' own FAQ states plainly it is "unable to change or cancel orders" once processing begins, with no stated grace period.
  • A single governing-law answer in the fine print matters to you — Kin Meds' own Terms of Use name Georgia as the governing law in one clause and California as the law an arbitrator would apply two clauses later.

What Kin Meds offers

Tap any compound to read our plain-English guide — what the evidence shows, how it is dosed, and what it costs elsewhere.

Who fills your prescription

No category stated

Kin Meds does not name the pharmacy that fills your prescription.

What its own site says

Unknown category, and internally contradicted. Kin Meds' own FAQ names one pharmacy directly and states it works "exclusively" with it (Rush Pharmacy, rushpharmacy.com, Oviedo, FL) — but its own Returns and Refund Policy gives a SECOND, different pharmacy's address as the return destination for the same prescription products (Kin Meds/Strive Pharmacy, Gilbert, AZ). Neither "503A" nor "503B" appears anywhere checked (About, FAQ, Terms of Use, Returns and Refund Policy, HIPAA Notice, or Privacy Policy) — only vague category language ("sourced from trusted American pharmacies," "US partner pharmacies").

What's the difference between 503A and 503B?

A 503A pharmacy compounds for one named patient; a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Compounded peptides are not FDA-approved.

Where you can get it

Not published

Not published as a list. Kin Meds' own FAQ states only, "We have nationwide coverage. If in doubt about a specific territory, please reach out" — a hedge, not a comprehensive list and not an plain "all 50 states" claim. No exclusion list appears anywhere on the site.

The honest cons

The part they would rather you skipped

FDA issued Kin Meds a warning letter (MARCS-CMS 721450, February 20, 2026, Center for Drug Evaluation and Research), addressed to 1590 Rosecrans Ave, Manhattan Beach, CA 90266 — the identical address confirmed against Kin Meds' own site-wide page data. The letter states FDA reviewed kinmeds.com in December 2025 and found the compounded semaglutide and tirzepatide products displayed on the site identified "Kin Meds" on the pictured label, suggesting Kin Meds is the compounder of those drugs when in fact it is not — misbranded under FDCA §§502(a) and 502(bb). Separately, and cited independently in the same letter, FDA named two specific marketing claims it says implied FDA approval or safety evaluation that never occurred: "Same Active Ingredient as common brands," and "Hit weight management goals with the same weight loss ingredient as brand-name GLP-1 medications, at a fraction of the cost" — the same two-separately-cited-claims shape as BluefitMD's letter from the identical wave. Neither quoted phrase appears on the live site today, consistent with post-letter remediation — the same pattern already documented for Strut Health. Independent of the letter, Kin Meds' own site contradicts itself about which pharmacy fills a prescription: its own FAQ states, "Kin Meds works exclusively with Rush Pharmacy" — but its own Returns and Refund Policy lists TWO different "Address for Returns" blocks for what should be the same prescription-medication flow: one for "Kin Meds / Rush Pharmacy" (1977 Alafaya Trail #1121, Oviedo, FL) and, separately on the same page, one for "Kin Meds/Strive Pharmacy" (1275 E Baseline Rd #104, Gilbert, AZ) — an unresolved, unedited contradiction of the exact "exclusively" claim made elsewhere on the same site. Also independent of the FDA letter: Kin Meds' own Terms of Use state the agreement is "governed by and construed in accordance with the laws of the State of Georgia" in its Governing Law clause, then state two clauses later that any dispute goes to "binding arbitration in San Diego, California" where "the arbitrator will apply the law in accordance with the laws of the State of California" — a real split between which state's law the Terms name as governing and which state's law an arbitrator would actually apply, the same shape (if a smaller one) as Ivim Health's Michigan-vs-Ohio jurisdiction contradiction already here.

  • FDA warning letter (MARCS-CMS 721450, Feb 20, 2026) over a mislabeled-compounder claim and two separately-cited marketing claims implying FDA approval — see this review's knock for the full, independently-verified finding.
  • Its own FAQ states it "works exclusively with Rush Pharmacy" — but its own Returns and Refund Policy separately names a second, different pharmacy (Strive Pharmacy) as the return address for the same prescription products, an unresolved first-party contradiction.
  • Its own Terms of Use name Georgia as the governing-law state in one clause, then name California as the law an arbitrator would apply two clauses later, in the same document.
  • Its own FAQ states plainly, "As soon as you place your order we begin processing it. Therefore, we are unable to change or cancel orders" — no grace period or same-day cancellation window found anywhere on the site.
  • No pharmacy is tied to a 503A/503B category anywhere on the site, despite two being named by name and address.
  • No state coverage list or plain "all 50 states" claim is published anywhere; the only statement is a hedge ("if in doubt about a specific territory, please reach out").
  • The marketing-page $249/mo and $349/mo prices could not be confirmed against Kin Meds' own checkout — its intake quiz is a separate booking app that shows no price when it first loads, and it could not be reached interactively.

None of this is unique to Kin Meds — the whole category shares it.

How it compares

Read this before you buy

A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.

Ready to get started?

Prices and plans in this category change often — check Kin Meds's current pricing before you decide. Ours was read from their own site in August 2026.

See Kin Meds pricing

Facts on this page reflect Kin Meds's own public disclosures when we last checked them, in August 2026. Prices and terms change without notice — confirm on Kin Meds's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.

Kin Meds

3 compounds from $199/mo

Visit